Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_assertion type Assertion NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_head.
- NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_assertion description "[We pharmacologically characterized pituitary adenylate cyclase-activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC(1), VPAC(2) and PAC(1) receptors in human meningeal (for their role in migraine) and coronary (for potential side effects) arteries.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_provenance.
- NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_assertion evidence source_evidence_literature NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_provenance.
- NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_assertion SIO_000772 20974589 NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_provenance.
- NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_assertion wasDerivedFrom befree-20140225 NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_provenance.
- NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_assertion wasGeneratedBy ECO_0000203 NP495932.RATaDp-Ylfos1Xgy0zljtuz1mWLEUe_PeunpzjH_TN6Zs130_provenance.